“The objectives of the next year’s strategic project are set, taking into account the ambitious plans to develop 200 new drugs by 2030,” the publication states.
DSTU noted that VIC Group, one of the largest producers of veterinary drugs in Russia, is among the leading partners of the project.
“DSTU has already initiated the collaborative development and pre-clinical studies of new veterinary medicines and vaccines,” clarified the university.
Furthermore, university researchers are working on the development of ready-to-use solutions for the next generation of feeds featuring prominent probiotic activity, from conception to launch.
The institution also aims to supply the industry with city veterinarians. Starting in September 2024, an educational experiment is set to launch in Russia to provide internships for veterinary professionals, with DSTU participating in this program.
“The One Health strategy is a project designed to address challenges such as antibiotic resistance and the replacement of imported veterinary drugs. It also aims to develop new products and technologies for diagnosing both human and animal diseases using artificial intelligence,” the statement says.
